Daratumumab in Combination With Urelumab to Potentiate Anti-Myeloma Activity in Lymphocyte-Deficient Mice Reconstituted With Human NK Cells

OncoImmunology - United States
doi 10.1080/2162402x.2019.1599636
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Daratumumab-Mediated Lysis of Primary Multiple Myeloma Cells Is Enhanced in Combination With the Human Anti-Kir Antibody IPH2102 and Lenalidomide

Haematologica
Hematology
2014English

Mice Treated With Strontium 90: An Animal Model Deficient in NK Cells

British Journal of Cancer
Cancer ResearchOncology
1981English

Clinical and Economic Study of Daratumumab in Combination Therapy for Previously Treated Patients With Multiple Myeloma

Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
2019English

Curcumin in Combination With Bortezomib Synergistically Induced Apoptosis in Human Multiple Myeloma U266 Cells

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2008English

Carboxypeptidase E Activity Is Deficient in Mice With thefatMutation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Disseminated Cryptococcosis in a Patient With Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone

Internal Medicine
Internal MedicineMedicine
2019English

CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-Expressing NK Cells in Mice With Established Peritoneal Xenografts

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2020English

Daratumumab in Untreated Newly Diagnosed Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2019English

Experimental Transmission of M. Leprae in Mice Treated With Anti-Lymphocyte Serum

Japanese journal of leprosy
1979English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy